{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:02:25Z","timestamp":1786114945841,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tjpad.2025.100101","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T07:31:08Z","timestamp":1741073468000},"page":"100101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Qualitative research and literature review support the integrated Alzheimer's Disease Rating Scale (iADRS) content validity in early symptomatic AD"],"prefix":"10.1016","volume":"12","author":[{"given":"Laure","family":"Delbecque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4323-9308","authenticated-orcid":false,"given":"Emma","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Cleanthous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alette M.","family":"Wessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra S.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.tjpad.2025.100101_bib0001","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100101_bib0002","doi-asserted-by":"crossref","first-page":"e13109","DOI":"10.1111\/acel.13109","article-title":"Amyloid-beta accumulation cycle\u201d as a prevention and\/or therapy target for Alzheimer's disease","volume":"19","author":"Rao","year":"2020","journal-title":"Aging Cell"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100101_bib0003","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2174\/1567205012666150701103107","article-title":"Alzheimer's disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions","volume":"12","author":"Raskin","year":"2015","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100101_bib0004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12877-020-01926-9","article-title":"The role of physical and cognitive function in performance of activities of daily living in patients with mild-to-moderate Alzheimer's disease \u2013 a cross-sectional study","volume":"20","author":"Clemmensen","year":"2020","journal-title":"BMC Geriatr"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100101_bib0005","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/arclin\/acw049","article-title":"Assessment of activities of daily living, self-care, and independence","volume":"31","author":"Mlinac","year":"2016","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100101_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100101_bib0007","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100101_bib0008","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","article-title":"Anti-amyloid immunotherapies for Alzheimer's disease: a 2023 clinical update","volume":"20","author":"Yadollahikhales","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100101_bib0009","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0088-24.2024","article-title":"What's in it for me? Contextualizing the potential clinical impacts of Lecanemab, Donanemab, and other anti-\u03b2-amyloid monoclonal antibodies in early Alzheimer's disease","volume":"11","author":"Jin","year":"2024","journal-title":"Eneuro"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100101_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100101_bib0011","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10654-018-0381-0","article-title":"The importance of endpoint selection: how effective does a drug need to be for success in a clinical trial of a possible Alzheimer's disease treatment?","volume":"33","author":"Evans","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.tjpad.2025.100101_bib0012","first-page":"1","article-title":"A combined measure of cognition and function for clinical trials: the integrated Alzheimer's disease rating scale (Iadrs)","author":"Wessels","year":"2015","journal-title":"J Prev Alzheimer's Dis"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100101_bib0013","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100101_bib0014","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis & Assoc Dis."},{"issue":"1","key":"10.1016\/j.tjpad.2025.100101_bib0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-020-00659-6","article-title":"Assessing what matters most to patients with or at risk for Alzheimer's and care partners: a qualitative study evaluating symptoms, impacts, and outcomes","volume":"12","author":"DiBenedetti","year":"2020","journal-title":"Alzheimer's Res & Ther"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100101_bib0016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40120-023-00445-0","article-title":"Assessing what matters to people affected by Alzheimer's disease: a quantitative analysis","volume":"12","author":"Hauber","year":"2023","journal-title":"Neurol and Ther"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100101_bib0017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40120-023-00443-2","article-title":"Technical review of clinical outcomes assessments across the continuum of Alzheimer's disease","volume":"12","author":"DiBenedetti","year":"2023","journal-title":"Neurol and Ther"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100101_bib0018","doi-asserted-by":"crossref","first-page":"507","DOI":"10.14283\/jpad.2022.41","article-title":"Clinical trial endpoints and their Clinical meaningfulness in early stages of Alzheimer's Disease","volume":"9","author":"Cohen","year":"2022","journal-title":"J Prev Alzheimer's Dis"},{"key":"10.1016\/j.tjpad.2025.100101_bib0019","series-title":"Research methods in health: investigating health and health services","author":"Bowling","year":"2009"},{"key":"10.1016\/j.tjpad.2025.100101_bib0020","series-title":"Analyzing qualitative data","author":"Bryman","year":"2002"},{"key":"10.1016\/j.tjpad.2025.100101_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6874-9-11","article-title":"Satisfaction and quality of life in women who undergo breast surgery: a qualitative study","volume":"9","author":"Klassen","year":"2009","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.tjpad.2025.100101_bib0022","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.tjpad.2025.100101_bib0023","series-title":"Proceedings of the Section on Survey Research Methods of the American Statistical Assocaition","article-title":"Survey procedures for conducting cognitive interview to prestest questionnaires: a review of theory and practice","author":"Blair","year":"1993"},{"key":"10.1016\/j.tjpad.2025.100101_bib0024","series-title":"Health measurement scales: a practical guide to their development and use","year":"2008"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100101_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/erp.10.30","article-title":"Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research","volume":"10","author":"Kerr","year":"2010","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100101_bib0026","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1098214005283748","article-title":"A general inductive approach for analyzing qualitative evaluation data","volume":"27","author":"Thomas","year":"2006","journal-title":"Am J of Eval"},{"key":"10.1016\/j.tjpad.2025.100101_bib0027","unstructured":"Friese, S ATLAS.Ti 7 user guide and reference 2015."},{"key":"10.1016\/j.tjpad.2025.100101_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2013.00033","article-title":"Perspectives on episodic-like and episodic memory","volume":"7","author":"Pause","year":"2013","journal-title":"Front in Behav Neurosci."},{"key":"10.1016\/j.tjpad.2025.100101_bib0029","series-title":"Palliative care for advanced alzheimer\u2019s and dementia: guidelines and standards for evidence-based care","author":"Martin","year":"2010"},{"key":"10.1016\/j.tjpad.2025.100101_bib0030","first-page":"79","volume":"24","author":"Munoz","year":"2010"},{"key":"10.1016\/j.tjpad.2025.100101_bib0031","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.dadm.2018.07.006","article-title":"The conceptual relevance of assessment measures in patients with mild\/mild-moderate Alzheimer's disease","volume":"10","author":"Hartry","year":"2018","journal-title":"Alzheimer's & Dement (Amst)"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100101_bib0032","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13195-020-00706-2","article-title":"Decline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuum","volume":"12","author":"Dubbelman","year":"2020","journal-title":"Alzheimer's Res & Ther"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:32:17Z","timestamp":1785972737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2274580725000457"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100101","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qualitative research and literature review support the integrated Alzheimer's Disease Rating Scale (iADRS) content validity in early symptomatic AD","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Eli Lilly and Company. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100101"}}